SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-030159
Filing Date
2021-03-01
Accepted
2021-03-01 17:28:30
Documents
24
Period of Report
2021-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218271d3_8k.htm   iXBRL 8-K 37624
2 EXHIBIT 4.1 tm218271d3_ex4-1.htm EX-4.1 106960
3 EXHIBIT 4.2 tm218271d3_ex4-2.htm EX-4.2 109789
4 EXHIBIT 5.1 tm218271d3_ex5-1.htm EX-5.1 31565
5 EXHIBIT 5.2 tm218271d3_ex5-2.htm EX-5.2 15054
6 EXHIBIT 10.1 tm218271d3_ex10-1.htm EX-10.1 222695
7 EXHIBIT 99.1 tm218271d3_ex99-1.htm EX-99.1 9649
11 GRAPHIC tm218271d3_ex5-1img001.jpg GRAPHIC 2626
12 GRAPHIC tm218271d3_ex5-2img002.jpg GRAPHIC 7886
13 GRAPHIC tm218271d3_ex5-2img003.jpg GRAPHIC 2014
14 GRAPHIC tm218271d3_ex5-2img004.jpg GRAPHIC 1822
15 GRAPHIC tm218271d3_ex5-2img005.jpg GRAPHIC 1822
16 GRAPHIC tm218271d3_ex99-1img001.jpg GRAPHIC 4535
  Complete submission text file 0001104659-21-030159.txt   863351

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nbrv-20210301.xsd EX-101.SCH 3184
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbrv-20210301_lab.xml EX-101.LAB 34592
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbrv-20210301_pre.xml EX-101.PRE 22709
17 EXTRACTED XBRL INSTANCE DOCUMENT tm218271d3_8k_htm.xml XML 3502
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 21699712
SIC: 2834 Pharmaceutical Preparations